Completed PHASE3 INTERVENTIONAL 2-arm NCT02379806

The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study (SYMPTOMS)

Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study

Sponsor: University Hospital, Brest

Conditions Venous Thromboembolism

Interventions Enoxaparin Placebo

Updated 14 times since 2017 Last updated: Jun 30, 2022 Started: Sep 3, 2015 Primary completion: Dec 31, 2020 Completion: Dec 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02379806, this PHASE3 trial focuses on Venous Thromboembolism and remains completed. Sponsored by University Hospital, Brest, it has been updated 14 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

14 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Sep 2022 — Jul 2024 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 9 earlier versions

Jan 2021 — Sep 2022 [monthly]

Recruiting PHASE3
Oct 2020 — Jan 2021 [monthly]

Recruiting PHASE3
Mar 2020 — Oct 2020 [monthly]

Recruiting PHASE3
Nov 2018 — Mar 2020 [monthly]

Recruiting PHASE3
Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE3
May 2018 — Jun 2018 [monthly]

Recruiting PHASE3
Jun 2017 — May 2018 [monthly]

Recruiting PHASE3
Feb 2017 — Jun 2017 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Brest

Data source: University Hospital, Brest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Agen, France , Angers, France , Angoulême, France , Arras, France , Bondy, France , Bordeaux, France , Brest, France , Béthune, France , Cherbourg, France , Colombes, France and 27 more locations